The implication of functional connectivity strength in predicting treatment response of major depressive disorder: A resting EEG study

Psychiatry Research - Neuroimaging

Volumn 194, Issue 3, 2011, Pages 372-377

  Lee, Tien Wen ^a   Wu, Yu Te ^b   Yu, Younger W Y ^c   Chen, Ming Chao ^d   Chen, Tai Jui ^e,f  

^a LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Yu's Psychiatric Clinic   (Taiwan)

^d KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

^e E DA HOSPITAL   (Taiwan)

^f I SHOU UNIVERSITY   (Taiwan)

Author keywords

Coherence; Electroencephalography (EEG); Major depression; Resting EEG; Spectrum

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE;

ADULT; ARTICLE; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL STATUS; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; BRAIN WAVES; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REST; TIME FACTORS;

EID: 82455162353     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.02.009     Document Type: Article

References (62)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC. 4th edition.
2. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biological Psychiatry 2005, 57:1079-1088.
3. Asada H., Fukuda Y., Tsunoda S., Yamaguchi M., Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neuroscience Letters 1999, 274:29-32.
4. Bae J.N., MacFall J.R., Krishnan K.R., Payne M.E., Steffens D.C., Taylor W.D. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biological Psychiatry 2006, 60:1356-1363.
5. Beck A.T. The evolution of the cognitive model of depression and its neurobiological correlates. American Journal of Psychiatry 2008, 165:969-977.
6. Brody A.L., Barsom M.W., Bota R.G., Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Seminars in Clinical Neuropsychiatry 2001, 6:102-112.
7. Bruder G.E., Stewart J.W., Tenke C.E., McGrath P.J., Leite P., Bhattacharya N., Quitkin F.M. Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biological Psychiatry 2001, 49:416-425.
8. Bruder G.E., Kayser J., Tenke C.E., Leite P., Schneier F.R., Stewart J.W., Quitkin F.M. Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks. Clinical Electroencephalography 2002, 33:119-124.
9. Bruder G.E., Sedoruk J.P., Stewart J.W., McGrath P.J., Quitkin F.M., Tenke C.E. Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. Biological Psychiatry 2008, 63:1171-1177.
10. Davidson R.J. Anterior cerebral asymmetry and the nature of emotion. Brain and Cognition 1992, 20:125-151.
11. Demaree H.A., Everhart D.E., Youngstrom E.A., Harrison D.W. Brain lateralization of emotional processing: historical roots and a future incorporating "dominance". Behavioral and Cognitive Neuroscience Reviews 2005, 4:3-20.
12. Desiraju T. Electrophysiology of the frontal granular cortex. III. The cingulate-prefrontal relation in primate. Brain Research 1976, 109:473-485.
13. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function 2008, 213:93-118.
14. Duffy F.H., Lyer G., Surwillo W.W. Clinical Electroencephalography and Topographical Brain Mapping 1989, Springer-Verlag, New York.
15. Fingelkurts A.A., Fingelkurts A.A., Rytsala H., Suominen K., Isometsa E., Kahkonen S. Impaired functional connectivity at EEG alpha and theta frequency bands in major depression. Human Brain Mapping 2007, 28:247-261.
16. Gainotti G., Caltagirone C., Zoccolotti P. Left/right and cortical/subcortical dichotomies in the neuropsychological study of human emotions. Cognition & Emotion 1993, 7:71-92.
17. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., Reiss A.L., Schatzberg A.F. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry 2007, 62:429-437.
18. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
19. Hamilton J.P., Gotlib I.H. Neural substrates of increased memory sensitivity for negative stimuli in major depression. Biological Psychiatry 2008, 63:1155-1162.
20. Harmer C.J., Goodwin G.M., Cowen P.J. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 2009, 195:102-108.
21. Heller W. Neuropsychological mechanisms of individual differences in emotion, personality, and arousal. Neuropsychology 1993, 7:476-489.
22. Hjorth B. An on-line transformation of EEG scalp potentials into orthogonal source derivations. Electroencephalography and Clinical Neurophysiology 1975, 39:526-530.
23. Hunter A.M., Cook I.A., Leuchter A.F. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatric Clinics of North America 2007, 30:105-124.
24. Ishii R., Shinosaki K., Ukai S., Inouye T., Ishihara T., Yoshimine T., Hirabuki N., Asada H., Kihara T., Robinson S.E., Takeda M. Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport 1999, 10:675-679.
25. Kaffenberger T., Bruhl A.B., Baumgartner T., Jancke L., Herwig U. Negative bias of processing ambiguously cued emotional stimuli. Neuroreport 2010, 21:601-605.
26. Kaiser G. A Friendly Guide to Wavelets 1994, Birkhauser, New York.
27. Kaiser S., Unger J., Kiefer M., Markela J., Mundt C., Weisbrod M. Executive control deficit in depression: event-related potentials in a Go/Nogo task. Psychiatry Research: Neuroimaging 2003, 122:169-184.
28. Kawasaki T., Tanaka S., Wang J., Hokama H., Hiramatsu K. Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials. Psychiatry and Clinical Neurosciences 2004, 58:68-75.
29. Kemp, A. H., Gordon, E., Rush, A. J., Williams, L. M., 2008. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr 13, 1066-86; quiz 1087-8.
30. Kemp A.H., Hopkinson P.J., Hermens D.F., Rowe D.L., Sumich A.L., Clark C.R., Drinkenburg W., Abdi N., Penrose R., McFarlane A., Boyce P., Gordon E., Williams L.M. Fronto-temporal alterations within the first 200ms during an attentional task distinguish major depression, non-clinical participants with depressed mood and healthy controls: a potential biomarker?. Human Brain Mapping 2009, 30:602-614.
31. Kimbrell T.A., Ketter T.A., George M.S., Little J.T., Benson B.E., Willis M.W., Herscovitch P., Post R.M. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry 2002, 51:237-252.
32. Knott V., Mahoney C., Kennedy S., Evans K. Pre-treatment EEG and its relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry 2000, 33:201-205.
33. Knott V., Mahoney C., Kennedy S., Evans K. EEG power, frequency, asymmetry and coherence in male depression. Psychiatry Research: Neuroimaging 2001, 106:123-140.
34. Knott V., Mahoney C., Kennedy S., Evans K. EEG correlates of acute and chronic paroxetine treatment in depression. Journal of Affective Disorders 2002, 69:241-249.
35. Konarski J.Z., McIntyre R.S., Kennedy S.H., Rafi-Tari S., Soczynska J.K., Ketter T.A. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disorders 2008, 10:1-37.
36. Korb A.S., Cook I.A., Hunter A.M., Leuchter A.F. Brain electrical source differences between depressed subjects and healthy controls. Brain Topography 2008, 21:138-146.
37. Kugaya A., Sanacora G., Staley J.K., Malison R.T., Bozkurt A., Khan S., Anand A., Van Dyck C.H., Baldwin R.M., Seibyl J.P., Charney D., Innis R.B. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biological Psychiatry 2004, 56:497-502.
38. Kumar A., Cook I.A. White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Developmental Neuroscience 2002, 24:255-261.
39. Lee T.W., Yu Y.W., Chen T.J., Tsai S.J. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. Journal of Psychiatry and Neuroscience 2005, 30:202-205.
40. Lopes da Silva F.H. Event-related neural activities: what about phase?. Progress in Brain Research 2006, 159:3-17.
41. Maletic V., Robinson M., Oakes T., Iyengar S., Ball S.G., Russell J. Neurobiology of depression: an integrated view of key findings. International Journal of Clinical Practice 2007, 61:2030-2040.
42. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
43. Meyer J.H. Applying neuroimaging ligands to study major depressive disorder. Seminars in Nuclear Medicine 2008, 38:287-304.
44. Moon T.K., Stirling W.C. Mathematical Methods and Algorithms for Signal Processing 2000, Prentice Hall, New Jersey.
45. Moratti S., Rubio G., Campo P., Keil A., Ortiz T. Hypofunction of right temporoparietal cortex during emotional arousal in depression. Archives of General Psychiatry 2008, 65:532-541.
46. Moses-Kolko E.L., Price J.C., Thase M.E., Meltzer C.C., Kupfer D.J., Mathis C.A., Bogers W.D., Berman S.R., Houck P.R., Schneider T.N., Drevets W.C. Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse 2007, 61:523-530.
47. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., Moller H.J., Hegerl U., Pogarell O. Prediction of treatment response in major depression: integration of concepts. Journal of Affective Disorders 2007, 98:215-225.
48. Papakostas G.I., Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience 2008, 10:439-451.
49. Papakostas G.I., Homberger C.H., Fava M. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Journal of Psychopharmacology 2008, 22:843-848.
50. Parsey R.V., Olvet D.M., Oquendo M.A., Huang Y.Y., Ogden R.T., Mann J.J. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 2006, 31:1745-1749.
51. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. International Journal of Psychophysiology 1994, 18:49-65.
52. Pfurtscheller G., Andrew C. Event-related changes of band power and coherence: methodology and interpretation. Journal of Clinical Neurophysiology 1999, 16:512-519.
53. Phothisonothai M., Nakagawa M. EEG-based fractal analysis of different motor imagery tasks using critical exponent method. International Journal of Biological, Biomedical and Medical Sciences 2006, 3:175-180.
54. Sackeim H.A., Prohovnik I., Moeller J.R., Brown R.P., Apter S., Prudic J., Devanand D.P., Mukherjee S. Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Archives of General Psychiatry 1990, 47:60-70.
55. Serretti A., Chiesa A., Calati R., Perna G., Bellodi L., De Ronchi D. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. International Clinical Psychopharmacology 2009, 24:1-18.
56. Siegle G.J., Carter C.S., Thase M.E. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. American Journal of Psychiatry 2006, 163:735-738.
57. Stahl S.M., Zhang L., Damatarca C., Grady M. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Journal of Clinical Psychiatry 2003, 64(Suppl. 14):6-17.
58. Starkstein S.E., Federoff J.P., Price T.R., Leiguarda R.C., Robinson R.G. Neuropsychological and neuroradiologic correlates of emotional prosody comprehension. Neurology 1994, 44:515-522.
59. Sumich A.L., Kumari V., Heasman B.C., Gordon E., Brammer M. Abnormal asymmetry of N200 and P300 event-related potentials in subclinical depression. Journal of Affective Disorders 2006, 92:171-183.
60. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 2006, 163:28-40.
61. Vogt B.A., Pandya D.N. Cingulate cortex of the rhesus monkey: II. Cortical afferents. Journal of Comparative Neurology 1987, 262:271-289.
62. Wellsa T.T., Beevers C.G. Biased attention and dysphoria: Manipulating selective attention reduces subsequent depressive symptoms. Cognition & Emotion 2010, 24:719-728.